tirzepatide iih Idiopathic Intracranial Hypertension in Children and Adolescents with Obesity: A Narrative Review Use of glucagon-like peptide-1 receptor

The treatment difference for change in HbA 1c between oral semaglutide and placebo was smaller in patients taking insulin and metformin than in those taking insulin alone, although the treatment difference was still clinically relevant

Wegovy works as a GLP-1 receptor agonist and Mounjaro activates both GLP-1 and GIP receptors

Diabetes and Cardiovascular Disease: Epidemiology, Biological Mechanisms, Treatment Recommendations and Future Research

Methods Data source The conduct of the present study was approved by the Clinical Practice Research Datalink (CPRD) Research Data Governance (#23_002545), the Research Ethics Board of Sunnybrook Health Sciences Centre (PIN: 6013), and the Research Ethics Board of University of Toronto (#46463)

So in the case with Ozempic, those are likely going to be the basis for the lawsuit claims